Plain-English translation of NCT06561906 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for patterns in brain scans, blood tests, genes, and thinking ability to help doctors catch Alzheimer's disease very early — before major symptoms appear. Researchers hope to create tools that can predict who is most likely to develop memory problems in the future, so treatment could start sooner when it might be most helpful.
Current treatments for Alzheimer's disease work best in the earliest stages, but doctors often don't catch the disease until it's already progressed. This study exists to find better ways to identify people at risk before they experience significant memory loss, which could open the door to earlier treatment and potentially slow or prevent the disease.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for visits where you'll have brain imaging scans (MRI), complete thinking and memory tests, and provide a blood sample for genetic and biomarker testing. The researchers will use this information to build computer models that can predict cognitive decline and identify who may be at risk for Alzheimer's disease. The study is enrolling about 1,000 people and is currently recruiting participants.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Enrollment target
~1,000 participants
Started
September 2020
Primary completion
July 2027
Age range
50 Years – 79 Years
Last updated on clinicaltrials.gov in August 2024.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.